Monocyte-derived S1P in the lymph node regulates immune responses.

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Sphingosine 1-phosphate (S1P) is a lipid chemoattractant guiding cell migration out of tissues into circulation.
• S1P gradients, particularly those involving S1P receptor 1, direct T cell egress from lymph nodes into the bloodstream.
• Knowledge gaps exist regarding S1P distribution in disease and its impact on immune responses.

Purpose of the Study:

• Investigate S1P concentration dynamics in lymph nodes during immune responses.
• Identify sources of S1P within lymph nodes during inflammation.
• Elucidate the role of CD69 and S1P receptor 5 (S1pr5) in S1P regulation by immune cells.
• Determine the effect of elevated S1P on T cell residence time and autoimmune disease severity.

Main Methods:

• Measurement of S1P concentrations in lymph nodes during immune responses.
• Analysis of S1P production by hematopoietic cells, including inflammatory monocytes.
• Assessment of CD69 expression and its correlation with S1pr5 levels.
• Studies on the impact of S1P levels on T cell residence time in lymph nodes.
• Evaluation of experimental autoimmune encephalomyelitis severity in mouse models.

Main Results:

• S1P concentration significantly increases in lymph nodes during immune responses.
• Inflammatory monocytes, not endothelial cells, were identified as a major source of S1P in this context.
• CD69 expression on inflammatory monocytes was linked to reduced S1pr5 levels, functioning as a 'stand-your-ground' signal.
• Elevated S1P levels prolonged T cell residence time within lymph nodes.
• Increased S1P exacerbated experimental autoimmune encephalomyelitis severity in mice.

Conclusions:

• Immune responses alter S1P gradients within lymph nodes, with inflammatory monocytes as key producers.
• CD69 plays a critical role in regulating S1P signaling and immune cell retention at inflammatory sites.
• Prolonged T cell residence in lymph nodes due to elevated S1P may influence T cell differentiation and disease pathogenesis.
• Targeting S1P signaling offers potential therapeutic strategies for autoimmune diseases.